Entegris To Buy ATMI For About $1.15B

The deal announced Tuesday brings together two key suppliers in the semiconductor industry to create a leader in advanced process materials, contamination control and wafer handling, Entegris said.

The company expects the acquisition to result in annual cost savings of about $30 million and immediately boost its adjusted earnings per share. It plans to fund the all-cash deal with a combination of existing cash and additional debt.

The deal remains subject to regulatory and shareholder approvals, along with other customary closing conditions.

Under the terms of the agreement, Entegris will pay $34 in cash for each ATMI share. The price represents a 26 percent premium over the company's Monday closing stock price.

The companies said the deal was worth about $850 million net of cash acquired, including the net cash proceeds from the sale of ATMI's LifeSciences business of $170 million.

Also on Tuesday, Entegris announced better-than-expected fourth-quarter results.

Entegris earned $23.1 million, or 17 cents per share, up from $11.3 million, or 8 cents per share, in the same quarter of 2012. Excluding one-time items, the company said it earned 18 cents per share.

Revenue rose 11 percent to $186.3 million from $167.8 million.

Analysts, on average, expected a profit of 13 cents per share on $170.4 million in revenue, according to FactSet.

For its first quarter, the company projected an adjusted profit of 10 cents to 14 cents per share on $165 million to $180 million in revenue. Analysts expect earnings of 14 cents per share on $172.8 million in revenue.